The Food and Drug Administration agreed on Friday to allow the pharmaceutical manufacturer Moderna to increase the formula for the coronavirus vaccine in each of its vials by up to 40%, according to The New York Times.
Sources told the Times that the move could allow the company to include up to 14 doses in each vial of the vaccine, instead of the current 10 doses, which would increase the country’s total vaccine supply by about 20%.
“It would be a big step forward,” Dr. Moncef Slaoui, the scientific leader of the Trump Administration’s program to develop a vaccine, told the Times. ” I think it will have an impact in the short term. ”
A company spokesman declined to comment to the newspaper on its discussions with regulators.
Earlier this week, the Biden government announced an agreement to purchase an additional 100 million doses of the Modern vaccine, which has provided the government with 41 million doses so far.
“We appreciate the confidence that the US government has shown in our COVID-19 vaccine,” Moderna’s CEO, Stéphane Bancel, said in a press release. ” We continue to increase our manufacturing capacity, both inside and outside the United States. Our goal is to bring our vaccine to as many people as possible around the world to help end this pandemic. It is encouraging and humiliating to know that more than 22 million Americans have already been protected with Moderna’s vaccine. ”
© 2021 Newsmax. All rights reserved.